Junan Li
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 27
- Cancer-related Molecular Pathways 20
- Pharmacology 13
- Pharmacy and Medical Practices 9
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Ming‐Daw Tsai (18 shared papers)Anjali Mahajan (6 shared papers)Ming Jye Poi (26 shared papers)Christopher M. Weghorst (17 shared papers)In‐Ja L. Byeon (5 shared papers)Thomas Lee Selby (4 shared papers)Thomas J. Knobloch (11 shared papers)Karen Louise Ericson (2 shared papers)
- Journals
- Biochemistry (12 papers)Molecular Carcinogenesis (7 papers)American Journal of Pharmaceutical Education (5 papers)Anticancer Research (5 papers)Journal of the American Pharmacists Association (4 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Junan Li
96 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 118
- Oncology 458
- Otorhinolaryngology 80
- Cancer Research 155
- Molecular Biology 685
- Periodontics 66
Countries citing papers authored by Junan Li
This map shows the geographic impact of Junan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junan Li more than expected).
Fields of papers citing papers by Junan Li
This network shows the impact of papers produced by Junan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junan Li. The network helps show where Junan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 514 | |
| 2 | 2011 | 278 | |
| 3 | 1998 | 133 | |
| 4 | 2021 | 97 | |
| 5 | 2002 | 84 | |
| 6 | 2015 | 69 | |
| 7 | 2019 | 53 | |
| 8 | 2008 | 52 | |
| 9 | 2020 | 46 | |
| 10 | 2001 | 44 | |
| 11 | 2004 | 41 | |
| 12 | 1999 | 40 | |
| 13 | 2019 | 37 | |
| 14 | Gankyrin, a biomarker for epithelial carcinogenesis, is overexpressed in human oral cancer. | 2011 | 30 |
| 15 | 2019 | 30 | |
| 16 | 2003 | 29 | |
| 17 | 2017 | 29 | |
| 18 | 2003 | 28 | |
| 19 | 2004 | 26 | |
| 20 | 2013 | 24 |
About Junan Li
Junan Li is a scholar working on Oncology, Pharmacology, Hematology, Otorhinolaryngology and Geriatrics and Gerontology, having authored 103 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), Pharmacy and Medical Practices (9 papers), Protein Structure and Dynamics (8 papers), Multiple Myeloma Research and Treatments (8 papers), Head and Neck Cancer Studies (7 papers), Research on Leishmaniasis Studies (5 papers), Innovations in Medical Education (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Oncology (458 citations), Otorhinolaryngology (80 citations), Cancer Research (155 citations), Molecular Biology (685 citations) and Periodontics (66 citations). Junan Li has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Ming‐Daw Tsai, Anjali Mahajan, Ming Jye Poi, Christopher M. Weghorst, In‐Ja L. Byeon, Thomas Lee Selby, Thomas J. Knobloch, Karen Louise Ericson, Paul E. O’Maille and Mitch A. Phelps. Their work appears in journals such as Biochemistry, Molecular Carcinogenesis, American Journal of Pharmaceutical Education, Anticancer Research and Journal of the American Pharmacists Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.